In a bladder cancer mouse model, a combination of JG-98 and the Hsp90 N-terminal inhibitor STA-9090 showed robust and statistically significant tumor growth stabilization as compared to a single agent alone. This evidence concerns the gene HSP90AA1 and neoplasm.